A comparison of the beta-adrenoceptor stimulant properties of salbutamol, orciprenaline and soterenol with those of isoprenaline.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D001993:Bronchodilator Agents / Q000494:pharmacology*; D002645:Chickens; D003106:Colon / Q000187:drug effects; D003964:Diaphragm / Q000187:drug effects; D004285:Dogs; D000431:Ethanol / Q000494:pharmacology*; D005260:Female; D006168:Guinea Pigs; D006614:Hindlimb / Q000098:blood supply; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007422:Intestines / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology*; D008297:Male; D009921:Metaproterenol / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012118:Resorcinols / Q000494:pharmacology*; D013451:Sulfonic Acids / Q000494:pharmacology*; D014132:Trachea / Q000187:drug effects; D014599:Uterus / Q000187:drug effects; D014649:Vas Deferens / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D010627:Phenethylamines; D012118:Resorcinols; D013451:Sulfonic Acids; D000431:Ethanol; D009921:Metaproterenol; D007545:Isoproterenol